MUC16 and neoplasm: In addition to more thoroughly investigating the possibility of tumor-specific splice variant formation, our ongoing efforts include identifying the amino acid sequences that form the CA125 epitopes, developing CA125-specific affinity agents that complement the antibodies used in the clinical assay, and elucidating the cellular processes behind MUC16’s role in immune evasion and metastasis.